
Carboplatin Paclitaxel in Ovarian Cancer
OncoPharm
00:00
Trial Population and Eligibility
John Bazar describes the study's selection of optimally debulked stage III ovarian cancer patients and surgical requirements.
Play episode from 03:16
Transcript


